Kane Biotech Acquires Novel Product to Combat Biofilms

Kane Biotech, a biotechnology company engaged in the development of products to prevent and disperse bacterial biofilms, announced that it has acquired the worldwide exclusive license to all human and industrial applications of the dispersin B enzyme from the University of Medicine and Dentistry of New Jersey.

ArriveNet (http://press.arrivenet.com/pro/article.php/627083.html)